Here you are Akrotiri - this should explain it for you.
Cheers,
Snoball.
-----------------------------------------------------------
Olaparib is given with chemo at the front end. In a phase II study at the moment. Article is misleading, it is not a Australian-led study but a study paid for by Astra Zeneca and is USA-led study.
This is the real article that has FACTS
http://www.bloomberg.com/news/2011-05-18/astrazeneca-s-olaparib-prolongs-remission-in-ovarian-cancer.html
Promising stuff for BRCA1/2 patients(about 10% of ovarian cancer patients)
olaparib, page-7
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |